Concepedia

Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy

Rana R. McKay, Nils Kroeger, Wanling Xie, Jae‐Lyun Lee, Jennifer J. Knox, Georg A. Bjarnason, Mary J. MacKenzie, Lori Wood, Sandy Srinivas, Ulka N. Vaishampayan,

European Urology · 2013 · 253 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger, Andrew J. Rowan, Stuart Horswell et al. · New England Journal of Medicine · 2012 · 7.8K citations · Full text

, , +14

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · Journal of Clinical Oncology · 2009 · 2.1K citations · Full text

, , +17

Phase 3 trial of everolimus for metastatic renal cell carcinoma

Robert J. Motzer, Bernard Escudier, Stéphane Oudard et al. · Cancer · 2010 · 1.1K citations

, , +17

Distribution of metastatic sites in renal cell carcinoma: a population-based analysis

Marco Bianchi, Maxine Sun, Claudio Jeldres et al. · Annals of Oncology · 2011 · 658 citations

, , +16

Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Tarek Mekhail, Rony M. Abou-Jawde, Gabriel BouMerhi et al. · Journal of Clinical Oncology · 2005 · 571 citations · Full text

, , +14